Swiss Federal Institute of Technology (ETH) Zurich spin-out Qvanteq raises CHF 4m ($4.3m).
Qvanteq, an ETH Zurich med-tech spin-out founded in 2009, has raised a CHF4m ($4.3m) in its series B round from private investors. Qvanteq plans to use the funds to obtains clinical proof of concept in a “First-in-Man” study. It also plans to acquire CE market approval for a coronary product. The firm said in a…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
